Quantcast
Search Daily Dose & Film Annex
Loading

BIO SmartBrief

Daily Dose Newsletter

Daily Dose Newsroom is a Daily Dose of Wall Street research and news in the Healthcare, Biotech, and Biomedical sectors.

____________________________________________________________________________

Entries in becker (2)

Thursday
May032012

REGISTRATION OPEN for MD Becker Partners' 3rd Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference

Registration is now open for MD Becker Partners' 3rd annual “Cancer Immunotherapy: A Long Awaited Reality” conference event in New York.  

This unique, single-day conference event unites founding visionary researchers, clinicians, business leaders, key investors, and other stakeholders to engage in discussions, exchange information, highlight opportunities, and showcase leading companies in the field of cancer immunotherapy. It will be held on Thursday, October 4, 2012, at the New York Academy of Medicine. 

JMP Securities, Cantor Fitzgerald and Roth Capital Partners return as event sponsors. 

To register or present, and for more information, please go to the Conference Website

 

Wednesday
Apr252012

MD Becker Partners 3rd Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference

On Thursday, October 4, 2012, MD Becker Partners will host its Third Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference at the New York Academy of Medicine in New York City.  This unique, single-day conference event unites founding visionary researchers, clinicians, business leaders, key investors, and other stakeholders to engage in discussions, exchange information, highlight opportunities, and showcase leading companies in the field of cancer immunotherapy.  
 
To view the keynote address and select plenary sessions and panel discussions from last year's event, please visit the firm's new YouTube page at: www.youtube.com/mdbeckerpartners
 
A direct link to last year's keynote address by Axel Hoos, M.D., Ph.D., Co-Chairman of the Cancer Immunotherapy Consortium, is displayed below:

MD Becker Partners is a boutique management and strategy consulting firm focusing on both public and private companies in the life science industry. We also work with venture capitalists, institutional investors, and others that provide capital to these companies. As a strategic advisor and partner, we provide a full range of services to help our clients increase visibility, unlock stakeholder value and access resources to grow their business. To accomplish this, we integrate relations, strategy, and operational capabilities and apply them to carefully conceived and expertly enacted tactics. Visit our website to learn more at www.mdbpartners.com.